Horror logo

Morbius (2022): A Vampire Flick That Missed the Mark

Jared Leto's transformation into Marvel's living vampire fails to breathe life into this lackluster adaptation.

By Kevin HudsonPublished 8 months ago 2 min read

🧬 Introduction: The Premise

Morbius introduces us to Dr. Michael Morbius (Jared Leto), a brilliant scientist suffering from a rare blood disorder. In a desperate attempt to cure himself, he experiments with bat DNA, inadvertently transforming into a vampire-like creature with superhuman abilities and an insatiable thirst for blood. Directed by Daniel Espinosa, the film aims to blend horror elements with superhero tropes, expanding Sony's Spider-Man Universe.

🎭 Performances: A Mixed Bag

Jared Leto delivers a subdued performance as Morbius, capturing the character's internal struggle but lacking the charisma to elevate the film. Critics noted his portrayal as "drearily dour," failing to inject the necessary energy into the role.

Matt Smith, portraying Morbius's surrogate brother Milo, brings a flamboyant flair that contrasts sharply with Leto's somber demeanor. His performance was one of the few aspects that received praise, providing a much-needed spark in an otherwise dull narrative.

🎬 Direction and Visuals: Style Over Substance

Espinosa's direction attempts to create a dark, gothic atmosphere, with scenes set in shadowy locales like New York City and the jungles of Costa Rica. However, the film's visual effects and action sequences have been criticized as uninspired and lacking coherence. The CGI, particularly during fight scenes, often appears muddled, detracting from the overall viewing experience.

📝 Script and Storytelling: A Confusing Narrative

The screenplay suffers from a lack of depth and clarity. Character motivations are poorly developed, and the plot progresses in a disjointed manner. Attempts at humor fall flat, and the film's tone oscillates between serious drama and campy horror without finding a cohesive balance.

🎞️ Post-Credit Scenes: A Misguided Attempt at Universe Building

Morbius includes post-credit scenes intended to tie the film into the larger Marvel universe. However, these scenes have been widely panned for their confusing nature and perceived lack of purpose. Critics described them as "the worst kind of unearned fan service," failing to generate excitement for future installments.

📊 Critical and Audience Reception

Rotten Tomatoes: 15% approval rating based on 285 reviews, with an average rating of 3.8/10. The consensus reads: "Cursed with uninspired effects, rote performances, and a borderline nonsensical story, this dreary mess is a vein attempt to make Morbius happen."

Metacritic: Score of 35 out of 100, indicating "generally unfavorable reviews."

CinemaScore: Average grade of "C+" from audiences, one of the lowest for a Marvel adaptation.

Despite the critical drubbing, Morbius managed a modest box office debut, topping the North American box office with $39.1 million in its opening weekend.

🔚 Conclusion: A Missed Opportunity

Morbius had the potential to offer a fresh take on the superhero genre by delving into horror elements and exploring a complex anti-hero. Unfortunately, the film's lackluster script, uneven performances, and confusing narrative choices result in a forgettable experience. While there are glimpses of what could have been, particularly in Matt Smith's energetic portrayal of Milo, the film ultimately fails to leave a lasting impression.

⭐ Final Rating: 2 out of 5

fictionmonstermovie reviewtv reviewsupernatural

About the Creator

Kevin Hudson

Hi, I'm Kamrul Hasan, storyteller, poet & sci-fi lover from Bangladesh. I write emotional poetry, war fiction & thrillers with mystery, time & space. On Vocal, I blend emotion with imagination. Let’s explore stories that move hearts

Reader insights

Be the first to share your insights about this piece.

How does it work?

Add your insights

Comments

There are no comments for this story

Be the first to respond and start the conversation.

Sign in to comment

    Find us on social media

    Miscellaneous links

    • Explore
    • Contact
    • Privacy Policy
    • Terms of Use
    • Support

    © 2026 Creatd, Inc. All Rights Reserved.